Symbol
Syndax Pharmaceuticals, Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$12.97
Current price of the stock
$2M
Trading volume of the stock
$1.1B
Market capitalization of the company
Small Cap
Category of market capitalization
19.37%
Long-term growth mean estimate
4.87
Mean analyst rating
183.62%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
0.00
Total debt to total equity ratio
6.99
Current ratio
100.00%
Gross profit margin
-716.62%
Operating profit margin
-716.62%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-673.01%
Pretax profit margin
-673.01%
Net profit margin
-22.96%
Measures profitability relative to shareholders' equity
-22.96%
ROE excluding intangible assets
-19.76%
Measures profitability relative to total assets
-22.96%
Measures profitability relative to invested capital
0.03
Asset turnover ratio
-
Inventory turnover ratio
3.56
Receivables turnover ratio
25.25
Average number of days it takes to collect receivables
-3.55
Measures valuation relative to earnings
-3.36
P/E based on future earnings estimates
69.25
Measures valuation relative to sales
3.03
Measures valuation relative to book value
-1.70
Measures valuation relative to operating cash flow
-1.70
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
